<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#0563C1;
        text-decoration:underline;}
p.xmsonormal, li.xmsonormal, div.xmsonormal
        {mso-style-name:x_msonormal;
        margin:0cm;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt">***apologies if you receive this more than once***<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p>&nbsp;</o:p></span></p>
<div>
<p class="xmsonormal" style="background:white"><b><u><span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;padding:0cm">PDRA &#8211;AI Methods In Mammography Intelligent Assessment (Closing 31 May 23:59)</span></u></b><o:p></o:p></p>
<p class="xmsonormal" style="background:white"><b><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;padding:0cm">&nbsp;</span></b><o:p></o:p></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;padding:0cm">The Alan Turing Institute are seeking to support the secondment and/or recruitment of 2x full-time
 postdoctoral research associates (up to 1.0 FTE for up to 21 months) </span><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif">with experience in one or more of the following areas: clinical trials study design, diagnostic tools evaluation and artificial
 intelligence.</span><o:p></o:p></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif">&nbsp;</span><o:p></o:p></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif">The role holder will develop novel methodologies and studies to assess the safety and efficacy of Mammography Intelligent Assessment (Mia), a novel
 AI breast screening solution, developed by Kheiron Medical on over 3 million images from different mammography modalities and different ethnic backgrounds.
<o:p></o:p></span></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:12.0pt"><o:p>&nbsp;</o:p></span></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif">Mia has recently been tested in a large-scale clinical trial in the UK and Europe with 283,000 cases (unseen and unenriched sample size).
</span><o:p></o:p></p>
<p class="xmsonormal" style="text-align:justify"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif">&nbsp;</span><o:p></o:p></p>
<p class="xmsonormal" style="background:white"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black">The successful candidates will be managed by the Senior Research Advisor, AI Methods within NHS Accelerated Access who has been appointed
 through open call and is now in post </span><o:p></o:p></p>
<p class="xmsonormal" style="background:white"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;padding:0cm">&nbsp;</span><o:p></o:p></p>
<p class="xmsonormal" style="background:white"><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;padding:0cm">Further information on the opportunities can be found here:
</span><span style="color:black"><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcezanneondemand.intervieweb.it%2Fturing%2Fjobs%2Fresearch_associate__ai_methods_in_mammography_intelligent_assessment_13995%2Fen%2F&amp;data=04%7C01%7CTuring-Southampton%40ecs.soton.ac.uk%7Ccdc19bb2d44f4882b5e208d91f9b5aea%7C4a5378f929f44d3ebe89669d03ada9d8%7C0%7C0%7C637575574359415379%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=U3HZysr%2B8H%2BAWzVofZQDehYTqZlyMeLlFBy6jWJZ%2Bb8%3D&amp;reserved=0" originalsrc="https://cezanneondemand.intervieweb.it/turing/jobs/research_associate__ai_methods_in_mammography_intelligent_assessment_13995/en/" shash="gHU6yP4NMkaTqnAmRFZeGv0TcwJNzgYZnOQPJJRUWXa0hZWg4JsTWWAhE44C1tnQ4GgCNEy+foosC0BAgWd37Jtk7iYoMx74g6pHD9ai02XrImVmrQRSKUFKMre7k3UpKr7sRPakuGFNNbqoDTp16ybuZXVrWxkKKkvJxnEX9Jw=">Cezanne
 OnDemand | Vacancies | Research Associate - AI methods in Mammography Intelligent Assessment (intervieweb.it)</a></span><o:p></o:p></p>
<p class="xmsonormal" style="background:white"><o:p>&nbsp;</o:p></p>
</div>
</div>
</body>
</html>